Post Marketing Surveillance of BI-Sifrol® (Pramipexole). Special Survey on Patients With Parkinson's Disease and Renal Dysfunction
Post Marketing Surveillance of BI-Sifrol® (Pramipexole). Special Survey on Patients With Parkinson's Disease and Renal Dysfunction
The survey is conducted to collect safety and effectiveness information targeting patients who have both Parkinson's disease and renal dysfunction treated with Pramipexole in the daily clinical settings in Japan.
Inclusion Criteria:
Patients with Parkinson's disease who have renal dysfunction with pretreatment creatinine clearance =<70mL/min or whose renal dysfunction was determined by the physician
Exclusion Criteria:
None
Tokyo Adachi-ku, Japan
Tokyo Bunkyo-ku, Japan
Tokyo Chiyoda-ku, Japan
Tokyo Itabashi-ku, Japan
Tokyo Meguro-ku, Japan
Tokyo Ota-ku, Japan
Tokyo Setagaya-ku, Japan
Tokyo Shibuya-ku, Japan
Tokyo Shinjuku-ku, Japan
Tokyo Suginami-ku, Japan